PROGRAM FACULTY
Gil Yosipovitch, MD
Professor of Dermatology
Stiefel Endowed Chair of Medical Dermatology
Director Miami Itch Center
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery
Miller School of Medicine
Coral Gables, FL
PROGRAM OVERVIEW
This educational activity will examine the burden of prurigo nodularis and the mechanisms of emerging therapies targeting the underlying pathophysiology of the disease. In addition, it will evaluate clinical trial data on the efficacy and safety of current and emerging treatment options and explain the how best to design personalized treatment plans incorporating systemic and topical agents to address symptoms and improve outcomes in patients with prurigo nodularis.
TARGET AUDIENCE
This activity is designed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and other health care providers who diagnose, treat, and/or manage patients with prurigo nodularis.
LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:
- Describe the burden of prurigo nodularis and the mechanism of emerging therapies target targeting the underlying pathophysiology of disease
- Assess clinical trial data on the efficacy and safety of current and emerging treatment options for prurigo nodularis
- Design personalized treatment plans for prurigo nodularis that incorporate systemic and topical agents to address symptoms and improve patient outcomes
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this enduring activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationships
| Speaker | Relationship | Manufacturer |
| Gil Yosipovitch, MD | Consultant | AbbVie, Arcutis, Escient Pharmaceuticals, Eli Lilly, Galderma, LEO Pharma, Novartis, Pfizer, Pierre Fabre, and Regeneron Pharmaceuticals. Contracted Research Eli Lilly, LEO Pharma, Novartis, Pfizer, Galderma, Escient Pharmaceuticals, Sanofi Regeneron, and Celldex Therapeutics. |
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
- Vaidehee Deshpande, Medical Services for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Emmanuella Foucault, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy
AMERICANS WITH DISABILITY ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to the enduring event at [email protected]
RELEASED DATE: October 16, 2023
EXPIRATION DATE: October 16, 2024
Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
